Endocan can be a predictive marker of severity of sepsis but cannot be a marker of acute respiratory distress syndrome in ICU patients
Mariko Mizunuma(Fukuoka University), Akira Murai(Fukuoka University), Yoshihiko Nakamura(Harvard University), Kentaro Muranishi(Fukuoka University Hospital), Hiroyasu Ishikura(Fukuoka University), Shinichi Morimoto(Fukuoka University Hospital), Hironari Kaneyama(Fukuoka University Hospital), Yoshito Izutani(Fukuoka University), Takeshi Nishida(Osaka Prefectural Medical Center)
Cited by 1
Related Papers
Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study
|Journal of Infection and Chemotherapy|2012|325
Brain-to-cervical lymph node signaling after stroke
|Nature Communications|2019|123
Presepsin as a powerful monitoring tool for the prognosis and treatment of sepsis: A multicenter prospective study
|Journal of Infection and Chemotherapy|2013|96
Post-Intensive Care Syndrome and Its New Challenges in Coronavirus Disease 2019 (COVID-19) Pandemic: A Review of Recent Advances and Perspectives
|Journal of Clinical Medicine|2021|91